These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clonal diversity in glioblastoma: is it clinically relevant? Watts C; Piccirillo SG Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436 [TBL] [Abstract][Full Text] [Related]
8. A silver lining on the horizon for glioblastoma. Knisely JP; Baehring JM Lancet Oncol; 2009 May; 10(5):434-5. PubMed ID: 19410186 [No Abstract] [Full Text] [Related]
9. EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation. Gursel DB; Schlaff CD; Boockvar JA Neurosurgery; 2012 Oct; 71(4):N17-8. PubMed ID: 22989968 [No Abstract] [Full Text] [Related]
10. Solving the riddle of glioblastoma: The hope for immunotherapy. Bashir R; Mohile NA Neurology; 2016 Jun; 86(24):2220-1. PubMed ID: 27225224 [No Abstract] [Full Text] [Related]
11. Genomic landscape of glioblastoma and the potential clinical utility. Wang CJ; Choe KS CNS Oncol; 2014 May; 3(3):169-72. PubMed ID: 25055121 [No Abstract] [Full Text] [Related]
12. Editorial: New Therapeutic Approaches for the Treatment of Glioblastoma. Festuccia C; Gravina GL Curr Cancer Drug Targets; 2017; 17(3):200-202. PubMed ID: 28322151 [No Abstract] [Full Text] [Related]
13. Advances in epigenetic glioblastoma therapy. Lee DH; Ryu HW; Won HR; Kwon SH Oncotarget; 2017 Mar; 8(11):18577-18589. PubMed ID: 28099914 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies for inhibiting invasion in glioblastoma. Drappatz J; Norden AD; Wen PY Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037 [TBL] [Abstract][Full Text] [Related]
16. Cure following gene therapy for recurrent glioblastoma multiforme? Karabatsou K; Bernstein M Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of immunotherapy resistance: lessons from glioblastoma. Jackson CM; Choi J; Lim M Nat Immunol; 2019 Sep; 20(9):1100-1109. PubMed ID: 31358997 [TBL] [Abstract][Full Text] [Related]
18. Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment. Mogilevsky M; Shimshon O; Kumar S; Mogilevsky A; Keshet E; Yavin E; Heyd F; Karni R Nucleic Acids Res; 2018 Nov; 46(21):11396-11404. PubMed ID: 30329087 [TBL] [Abstract][Full Text] [Related]
19. An unusual loss of EGFR gene copy in glioblastoma multiforme in a child: a case report and analysis of a successfully derived HGG-02 cell line. Veselska R; Skoda J; Loja T; Zitterbart K; Pavelka Z; Smardova J; Valaskova I; Hermanova M; Sterba J Childs Nerv Syst; 2010 Jun; 26(6):841-6. PubMed ID: 20195615 [TBL] [Abstract][Full Text] [Related]